Source
- HRSA HIV/AIDS Bureau (HAB) (206)
- IHIP (155)
- Best Practices Compilation (122)
- Data Integration, Systems and Quality (DISQ) Team (122)
- Center for Quality Improvement and Innovation (CQII) (106)
- ACE TA Center (88)
- IHAP TA Center (84)
- Planning CHATT (59)
- Ryan White Data Support (51)
- Technical Assistance Provider Innovation Network (TAP-in) (42)
- NASTAD (26)
- Cleveland/Lorain/Elyria TGA (26)
- Center for Innovation and Engagement (22)
- The HIV, Housing & Employment Project (17)
- Primary Care Development Corporation (PCDC) (15)
- Rapid ART Dissemination Assistance Provider (15)
- Boston University School of Social Work Center for Innovation in Social Work and Health (12)
- Evidence-Informed Interventions (E2i) (11)
- Unmet Need Training and TA Team (9)
- Strengthening Systems of Care for People with HIV and Opioid Use Disorder (9)
- CRE TA Center (8)
- New York State Department of Health AIDS Institute (8)
- National Minority AETC (8)
- NMAC (7)
- National Quality Center (6)
- Dissemination of Evidence Informed-Interventions Project (DEII) (6)
- Centers for Disease Control and Prevention (CDC) (6)
- National Center for Innovation in HIV Care (5)
- Center for Engaging Black MSM across the Care Continuum (5)
- U.S. Department of Health and Human Services (5)
- Wisconsin Department of Health Services (4)
- In It Together (4)
- SPNS Improving Care and Treatment Coordination Black Women with HIV (4)
- SPNS HIV/HCV Data-to-Care Initiative (4)
- TargetHIV (4)
- University of Washington (3)
- AETC National Coordinating Resource Center (NCRC) (3)
- Center for Advancing Health Policy and Practice (3)
- HRSA/SPNS Workforce Initiative (3)
- AIDS Alliance for Children Youth and Families (3)
- HRSA (3)
- Boston University School of Public Health (3)
- Hartford Department of Health and Human Services (3)
- U.S. Department of Housing and Urban Development (2)
- Multnomah County Health Department (2)
- Abt Associates (2)
- Philadelphia Office of HIV Planning (2)
- SPNS Black MSM Initiative (2)
- SPNS Housing Data Integration (2)
- AIDS Action Foundation (2)
- Massachusetts Department of Public Health (2)
- New Haven EMA (2)
- Dallas EMA (2)
- Indianapolis TGA (2)
- University of California, San Francisco (2)
- SAIC (1)
- HIV.GOV (1)
- HIV/AIDS Medical Homes Resource Center (HIV-MHRC) (1)
- West County Health Centers (1)
- EGM Consulting LLC (1)
- Howard Brown Health Center (1)
- RAND Corporation (1)
- NC-LINK (1)
- Louisiana Department of Health and Hospitals (1)
- Futures Without Violence (1)
- Hudson County HIV/AIDS Services Planning Council (1)
- Boston EMA HIV Services Planning Council (1)
- SPNS Transgender Women of Color Initiative (1)
- SPNS Systems Linkages Project (1)
- Broward County HIV Health Services Planning Council (1)
- Greater Baltimore HIV Health Services Planning Council (1)
- PLOS ONE (1)
- New York City Planning Council (1)
- The Bronx Health and Housing Corporation (1)
- Southeastern Michigan HIV/AIDS Council (1)
- Next Step and Mass CARE (1)
- SPNS Social Media Initiative (1)
- National Council for Behavioral Health (1)
- SPNS Latino Access Initiative (1)
- HRSA HIV/AIDS Bureau (HAB) and Centers for Disease Control and Prevention (CDC) (1)
- Yale University School of Medicine (1)
- SPNS Sexually Transmitted Infections Initiative (1)
- San Francisco Department of Public Health and Transgender Health Services Working Group (1)
- DC Department of Health (1)
- Ohio Department of Health (1)
- National Clinician Consultation Center (1)
- Public Health Foundation (1)
- HRSA HIV/AIDS Bureau (HAB) and NMAC (1)
- Indian Health Service (IHS) (1)
- EHE Systems Coordination Provider (1)
- SPNS HIV/STI Data Linkages (1)
- University of Texas Health, San Antonio (1)
- SPNS HCV Cure among People of Color with HIV (1)
- SPNS EnhanceLink (1)
- API Wellness Center (1)
- UCSF Center for AIDS Prevention Studies (1)
- National Native American AIDS Prevention Center (1)
- SAMHSA (1)
- Cicatelli Associates (CAI) (1)
- Virginia Department of Health (1)
- HRSA Bureau of Primary Health Care (BPHC) (1)
- Philadelphia Prevention Community Planning Group (1)
- HRSA Office of Pharmacy Affairs (OPA) (1)
- PEPFAR (1)
Display as
2205 items found
Documents • 06/01/2022
Documents • 02/11/2022
Documents • 02/10/2022
Conference Presentations • 02/09/2022
Conference Presentations • 02/09/2022
Conference Presentations • 02/09/2022
Conference Presentations • 02/09/2022
Conference Presentations • 02/08/2022
Conference Presentations • 02/08/2022
Conference Presentations • 02/08/2022
Conference Presentations • 02/07/2022
Conference Presentations • 02/07/2022
Conference Presentations • 02/07/2022
Conference Presentations • 02/07/2022
Conference Presentations • 02/07/2022
Conference Presentations • 02/07/2022
Conference Presentations • 02/07/2022
Conference Presentations • 02/07/2022
Conference Presentations • 02/09/2022
Conference Presentations • 02/08/2022
Conference Presentations • 02/07/2022
Conference Presentations • 02/07/2022
![](/sites/default/files/media/images/2021-06/Escalate-Logo-trans.png)
Documents • 06/01/2022
The purpose of the ESCALATE training program is to facilitate transformative and relational change in Ryan White HIV/AIDS Programs (RWHAP) and the commu
Documents • 02/11/2022
Excel tool to collect and analyze all HIV resources in the jurisdiction, as required by the Integrated HIV Prevention and Care Guidance, including the Statewide Coordinated Statement of Need, CY 2022-2026.
Documents • 02/10/2022
Policy blogs on health coverage issues for Ryan White HIV/AIDS Program (RWHAP) managers, staff, and enrollment assisters.
Conference Presentations • 02/09/2022
Review of options for PrEP in patients with decreased kidney function and low bone mineral density; the state of the science on STI prevention strategies; and recent data on the safety and efficacy on injectable PrEP options.
Conference Presentations • 02/09/2022
Review of the diagnostic and management strategies for the most common sexually transmitted infections based on the updated 2021 CDC STI Treatment Guidelines.
Conference Presentations • 02/09/2022
Identification of the five stages of the HIV care continuum; definition of how Data to Care supports the HIV Care Continuum and the six steps to get patients back to a healthcare practice.
Conference Presentations • 02/09/2022
Discussion of recognizing the signs of burnout among clinicians and strategies for self-care.
Conference Presentations • 02/08/2022
Review of antiretroviral therapy for women planning to get pregnant and during pregnancy; treatment for acute HIV infection during pregnancy; preexposure prophylaxis to prevent HIV transmission during pregnancy; and HIV infection- and breastfeeding-related issues.
Conference Presentations • 02/08/2022
Review of the differential diagnosis, management and treatment of depressive illnesses among people with HIV.
Conference Presentations • 02/08/2022
Review of overall trends, increased incidence, and screening regarding non-AIDS-defining cancers for people with HIV.
Conference Presentations • 02/07/2022
Review of the epidemiology of adolescents living with HIV; risk factors for developing comorbidities over the life course among adolescents with HIV; and opportunities to prevent comorbidities and optimize outcomes.
Conference Presentations • 02/07/2022
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.
Conference Presentations • 02/07/2022
Review of key components of Geriatric Assessment through the 5Ms framework; practical assessment tools for cognitive impairment and falls; and strategies to ask and address social isolation and loneliness.
Conference Presentations • 02/07/2022
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.
Conference Presentations • 02/07/2022
Review of the magnitude of weight gain associated with antiretroviral therapy; predictors of weight gain on antiretroviral therapy; and potential mechanisms and metabolic complications with weight gain during antiretroviral therapy.
Conference Presentations • 02/07/2022
Moderated discussion (Saag, Cheever) of those that were involved at the very start of the HIV/AIDS epidemic in the San Francisco Bay Area.
Conference Presentations • 02/07/2022
Review of COVID-19 risks in people with HIV (PWH), covering: risks; vaccination and prevention measures; and treatment considerations.
Conference Presentations • 02/07/2022
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.